Press Release October 22, 2021INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Novavax, Inc. and Encourages Investors with Losses to Contact the Firm 0 0 Share
Press Release October 22, 2021ComEd Fills Tuition Gap for 10 Local Engineering Students Pursuing STEM Careers 0 0 Share
Press Release October 22, 2021NETSOL Technologies Interview to Air on Bloomberg U.S. on the RedChip Money Report® 0 0 Share
Press Release October 22, 2021U.S. CDC Advisory Committee on Immunization Practices Recommends Booster Vaccination with Moderna's COVID-19 Vaccine 0 0 Share
Press Release October 22, 2021Dupixent® (dupilumab) is the First Biologic to Significantly Reduce Itch and Skin Lesions in Phase 3 Trial for Prurigo Nodularis, Demonstrating the Role of Type 2 Inflammation in this Disease 0 0 Share
Press Release October 22, 2021Dupixent® (dupilumab) is the first biologic to significantly reduce itch and skin lesions in Phase 3 trial for prurigo nodularis, demonstrating the role of type 2 inflammation in this disease 0 0 Share
Press Release October 21, 2021Dada Now Introduced On-demand Delivery Solutions for Chain Merchants at 2021 CFLP China E-commerce Logistics Conference 0 0 Share
Press Release October 21, 2021New Claro Box TV Brings World-Class Streaming Service with Harmonic's Cloud-Native Software 0 0 Share
Press Release October 21, 2021Allstate Announces September 2021 and Third Quarter 2021 Catastrophe Losses and Run-off Reserve Review 0 0 Share
Press Release October 21, 2021HAGENS BERMAN, NATIONAL TRIAL ATTOREYS, Encourages Novavax (NVAX) Investors with Significant Losses to Contact Firm's Attorneys Now, Firm Investigating Possible Securities Law Violations 0 0 Share
